Mobile Augmented Screening Tool to Increase Adolescent HIV Testing and Linkage to Care

NCT03939455 | Completed

• 1 other identifier: Moile Augmented Screening
• Study Type: interventional
• Target: 295
• Locations: 1 country
• Sites: 1

Brief Summary

Because adolescents and young adults face markedly increased HIV risk yet frequently do not test, we propose to complete the Mobile Augmented Screening (MAS) tool designed to increase HIV testing, and to facilitate linkage to care and ongoing prevention education. This tool will help clinicians address undiagnosed youth HIV, and enable young patients to receive much needed treatment and avoid unknowingly transmitting infection. Our product is designed to help existing program staff reach an increased number of clients; and to improve public health by encouraging reluctant young patients to accept important HIV testing and care they may otherwise decline.

Conditions

HIV Testing

Outcome Measures

Primary Outcomes (1)

• HIV testing

  The main outcome is participant HIV testing. We will measure whether the participant accepts an HIV test when offered. Possible outcomes are Yes or No.

  Day of study participation.

Study Arms (2)

Experimental

EXPERIMENTAL

Participants will complete a brief tablet-based intervention, which includes watching a 5 minute educational video on the importance of HIV testing, and respond via tablet computer to the offer of an HIV test.

Other: Mobile Augmented Screening tool

Treatment as usual

NO INTERVENTION

Participants will be offered an HIV test by hospital staff, and will respond face-to-face.

Interventions

Mobile Augmented Screening tool OTHER

Tablet-based intervention

Experimental

Eligibility Criteria

• Age: 13 Years - 24 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64)

You may qualify if:

• Emergency Department patients aged 13 - 24 years will be eligible for the study if they are:
• awake
• able to provide consent as determined by ED staff
• understand written and spoken English
• not intoxicated
• not known to be HIV positive
• not a prisoner
• have not already agreed to test for HIV during their current ED visit (this will include patients who decline HIV testing offered by hospital staff and patients who are not yet offered HIV testing; potential differences in test rates among participants who decline vs. those who have not previously been offered an HIV test will be explored as a secondary outcome)

Sponsors & Collaborators

• New York University: lead

Study Sites (1)

Columbia University Medical Center

New York, New York, 10032, United States

Location

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: SCREENING
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 30, 2019
• First Posted: May 6, 2019
• Study Start: July 22, 2019
• Primary Completion: March 5, 2020
• Study Completion: June 1, 2020
• Last Updated: May 13, 2021

Record last verified: 2021-05

Locations

US (1)